Kejing Ying

10PUBLICATIONS
11CO-AUTHORS
Medical infection agents (incl. prions)ChiropracticCardiology (incl. cardiovascular diseases)Haematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 22, 2025
Macrophage ferroptosis potentiates GCN2 deficiency induced pulmonary venous arterialization.

Jingyuan Zhang, Pei Mao, Tengfei Zhou

|Aug 09, 2024
Anti-Helicobacter pylori Infection Treatment and Pulmonary Hypersensitivity: Case Series and Review of the Literature.

Shan Xu, Xiaohong Wu, Enguo Chen

|Jun 04, 2024
What Is the Impact of Baseline Inflammatory and Hemostatic Indicators with the Risk of Mortality in Severe Inpatients with COVID-19: A Retrospective Study.

Huiqi Zhu, Yeping Li, Hua Su

|Jan 22, 2024
NanoSHP099-Targeted SHP2 Inhibition Boosts Ly6Clow Monocytes/Macrophages Differentiation to Accelerate Thrombolysis.

Kejing Ying, Wanghao Xin, Yiming Xu

|Nov 20, 2023
Incidentally Diagnosed With Pulmonary Embolism in Lung Cancer Patients: Comparison of Clinical Characteristics and Mortality With Symptomatic Pulmonary Embolism.

Zhuanbo Luo, Ning Xu, Guofeng Ma

|Jun 21, 2023
CircItgb5 promotes synthetic phenotype of pulmonary artery smooth muscle cells via interacting with miR-96-5p and Uba1 in monocrotaline-induced pulmonary arterial hypertension.

Hua Su, Huiqi Zhu, Sihao Wang

Pageof 2

Frequent Collaborators

1 joint publications

Jianchang Yao

1 joint publications

Wanghao Xin

1 joint publications

Huiqi Zhu

1 joint publications

Jingyuan Zhang